Navigation Links
Specialty Pharmacy Certification Board Announces Inaugural Board of Directors
Date:9/19/2012

TAMPA, Fla., Sept. 19, 2012 /PRNewswire-iReach/ -- (September 18, 2012) The Specialty Pharmacy Certification Board™ (SPCB™) announced its inaugural Board of Directors today.   SPCB selected Board members that represent a wide range of specialty pharmacy industry stakeholders from across the United States.

"We are pleased to welcome distinguished industry leaders to SPCB," Gary M. Cohen, BSPharm, RPh, Executive Director said, "Their knowledge, experience, and dedication will play a vital role in developing the Certified Specialty Pharmacist (CSP™) program."

The 2012 SPCB Board of Directors includes:

  • Jeffrey Bourret, RPh, MS, FASHP, Pfizer, Inc.
  • Nick Calla, RPh, Community Specialty Pharmacy Network
  • Donald Filibeck, PharmD, MBA, Critical Care Systems
  • Sandra Matsumoto, RPh, CVS Caremark
  • Gary Rice, RPh, MS, MBA, Diplomat Specialty Pharmacy
  • Ray Tancredi, RPh, MBA, BCPS, Walgreens
  • George Zula, RPh, MBA, US Bioservices

"I am pleased to serve on the board of directors for SPCB.  The specialty pharmacy segment has long needed a group to oversee credentialing and education of the specialty pharmacist in a more uniform manner. I am confident that the work of this group will move us forward in achieving that goal," said Nick Calla, RPh, Vice President of Industry Relations at Community Specialty Pharmacy Network.

The SPCB is dedicated to promote the Specialty Pharmacist's responsibility in maintaining the highest possible quality standards, to advocate for professional development to ensure that specialty patients receive appropriate care now and in the future, and to provide certification and credentialing programs for healthcare professionals to assure protection of the public.

SPCB

http://www.spcboard.org

Media Contact: Gary M. Cohen, BSPharm, R
'/>"/>

SOURCE Specialty Pharmacy Certification Board
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
2. Diplomat Specialty Pharmacy Honored By Inc. Magazine as One Of The Nations Fastest-Growing Companies for Fourth Consecutive Year
3. Advanced Specialty Rx
4. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
5. New Specialty Pharmacy Certification Board to Certify Specialty Pharmacists
6. Diplomat Specialty Pharmacys 2012 Physician Satisfaction Survey Results Affirm Success of Companys Education & Training Program
7. Diplomat Specialty Pharmacy Promotes Dr. Atheer Kaddis to Sr. Vice President of Sales and Marketing
8. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
9. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
10. Specialty Silicone Fabricators Inaugurates New State-of-the-Art Facility in Paso Robles
11. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global A Dialyzer Reprocessing Machine (A ... to their offering. The Global A ... Report 2014 is a professional and in-depth study ... reprocessing machine industry. The report provides a ...
(Date:6/1/2015)... CAMBRIDGE, Mass. , June 1, 2015  Boston ... compounds designed to target cancer stem cell (CSC) pathways, ... BBI608 and BBI503 in multiple tumor types at the ... in Chicago . Data ... an orally-administered investigational agent that targets STAT3, leading to ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... NEW YORK , July 6 Reportlinker.com announces that a ... , , ... and leading players , , ... http://www.reportlinker.com/p0233961/Opportunities-in-Non-Surgical-Bio-Implants-Marketed-injectable-biomaterials-applications-and-leading-players.html , , , ...
... OXFORD, England and LANGHORNE, ... a transatlantic specialty pharmaceutical company focused on,oncology, pain control ... Japanese development and commercialization rights to its oncology therapy,Erwinase(R) ... product partnership EUSA has established in Japan . ...
Cached Medicine Technology:Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 2Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 3Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 4Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 5Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 6Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 7Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 8Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 9Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 10Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players 11EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical 2EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical 3
(Date:6/1/2015)... IPSWICH, Mass. (PRWEB) June 01, 2015 ... decision support solutions, today introduced DynaMed Plus™ , ... and other medical professionals. It provides clinicians with the ... determine optimal patient care paths. , DynaMed Plus ... the market and includes the most frequently updated evidence-based ...
(Date:6/1/2015)... PA (PRWEB) June 01, 2015 Note: ... new development in breast cancer prevention. , A phase ... suggests that postmenopausal women with ductal carcinoma in situ ... treatment and prevention. , The study (NSABP B-35/NRG Oncology) ... who completed the standard five-year treatment with tamoxifen to ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 There’s never a ... when it comes to non-emergency, minor illnesses. , As of ... 24/7 online access to medical care via the Internet. Patients ... smartphone, tablet or computer. , “Everyone is busy. We know ... a challenge, so we want to make it easier,” said ...
(Date:6/1/2015)... Texas (PRWEB) June 01, 2015 Carrick ... brain health landscape on a global level. This ... realms, allowing Carrick Brain Centers to broaden their scope ... healing. , Broadened horizons are accompanied by a restructuring ... 1, 2015, Carrick Brain Centers will separate itself from ...
(Date:6/1/2015)... 01, 2015 A University of ... inhibits signaling proteins that activate protein degradation, which ... exercise. 1 , The study published April ... male Spraque-Dawley rats 2-3 months of age who ... were given either whey protein (.4g/kg), low-dose Sustamine ...
Breaking Medicine News(10 mins):Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Carrick Brain Centers announces separation from Dr. Frederick Carrick to reflect the broader scope of impact and growth as an organization. 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
... PRINCETON, N.J., July 15 Diabetes patients taking ... insulin in their pump for up to six days following ... labeling change, diabetes care company Novo Nordisk announced today.(1) The ... pump reservoir for two days. This makes NovoLog((R)) the first ...
... likely to keep education a priority, research finds , ... more likely than their Chinese counterparts to lose interest ... children outperform Americans in academic pursuits such as math, ... and Chinese students in grades 7 and 8, more ...
... , WASHINGTON, July 15 Steele will ... spelling out what Republicans are for and what they are against while ... care plan would do for ordinary Americans. , ... , The Senate Health, Education, Labor and ...
... 15 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) ... preparing for the tender business of 250,000 doses of ... can be viewed by visiting this web page directly ... batch exported to Indonesia this year by the company. ...
... WASHINGTON, July 15 Speaker Nancy Pelosi issued the following ... health care reform legislation: , , ... the Senate HELP Committee is further evidence of great momentum in ... of trying, this puts us one step closer to real reforms ...
... , Recent Death of Infant in ... SILVER SPRING, Md., July 15 The American Society for Parenteral ... the science and practice of nutrition support therapy, is saddened by the recent ... to him through an IV catheter and not through a feeding tube in ...
Cached Medicine News:Health News:FDA Approves NovoLog(R) Labeling Update 2Health News:FDA Approves NovoLog(R) Labeling Update 3Health News:FDA Approves NovoLog(R) Labeling Update 4Health News:U.S. Students' Academic Interests Tend to Wane in Middle School 2Health News:Hard To Treat Diseases (HTDS.PK) Tender Order To Indonesia 2Health News:Tube Feeding Error: Fatal Medical Mistakes 2Health News:Tube Feeding Error: Fatal Medical Mistakes 3
The Shandon Linistain SLS Linear Stainer is an economical mid-size linear stainer for staining procedures that do not require heat....
... The Shandon Finesse E+ is ... provides automated specimen advance with ... balanced flywheel is easy to ... the user the option of ...
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor....
... is a service that directly connects ... the customers laboratory to the Thermo ... U.S.A., and Runcorn, U.K.* By using ... customer site, high-value support services are ...
Medicine Products: